This study covered the literature on PD-1/PD-L1 inhibitor immunotherapy for lung cancer over the past fourteen years and analyzed it statistically by publication count, contributing countries, institutions, authors, referenced works, keywords, and research trends. This evidence concerns the gene CD274 and lung carcinoma.